Athenahealth shares have tumbled following recent media coverage that strategics such as UNH and Cerner are walking away from the process.  Perhaps Elliott buying ATHN isn't the best-case-scenario for investors, but it's still a scenario that is worth examining.

Yum China plummeted to $30 last week after headlines that Hillhouse is ending its pursuit, but is the process truly over?

CBS:  Is it now in play?

Athenahealth shares have tumbled following recent media coverage that strategics such as UNH and Cerner are walking away from the process. Perhaps Elliott buying ATHN isn't the best-case-scenario for investors, but it's still a scenario that is worth examining. Yum China plummeted to $30 last week after headlines that Hillhouse is ending its pursuit, but is the process truly over? CBS: Is it now in play?

AthenaHealth, Yum China, CBS, AEL & ESL

Michael Samuels, Founder and Portfolio Manager of  Broome Street Capital, talks M&amp;A, activism and event-driven investing, all with a focus on the news-sources that cover them. @accordtosources

Business

Investing

Michael Samuels, Founder and Portfolio Manager of Broome Street Capital, talks M&A, activism and event-driven investing, all with a focus on the news-sources that cover them. @accordtosources

Share AthenaHealth, Yum China, CBS, AEL & ESL

Sign up to save your podcasts

AthenaHealth, Yum China, CBS, AEL & ESL

AthenaHealth, Yum China, CBS, AEL & ESL